Company Filing History:
2 out of 151 
2 out of 1,179 
Years Active: 2021-2023
Title: Martin Wolfsegger: Innovator in Pharmacokinetic Drug Dosing Regimens
Introduction
Martin Wolfsegger is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmacokinetics, particularly in drug dosing regimens. With a total of 3 patents to his name, his work has the potential to greatly impact patient care and treatment outcomes.
Latest Patents
Wolfsegger's latest patents focus on methods and apparatuses for providing pharmacokinetic drug dosing regimens. One of his notable inventions involves systems and methods for providing a clotting factor VIII dosing regimen. This innovation includes determining an estimated pharmacokinetic profile of a patient using a Bayesian model. The systems can establish a first dosing regimen that varies over time based on the patient's estimated pharmacokinetic profile. Additionally, it allows for adjustments based on previous patient treatments, ensuring that therapeutic plasma protein levels remain within target ranges.
Another patent addresses the collection of blood samples from patients after an infusion of clotting factor VIII. This method determines the clearance of clotting factor VIII and assesses whether a patient has a half-life greater than a predetermined threshold. The pharmacokinetic profile is then established using a Bayesian model, which applies different weights based on the patient's half-life. This tailored approach leads to more effective dosing regimens for patients.
Career Highlights
Throughout his career, Martin Wolfsegger has worked with prominent companies in the pharmaceutical industry, including Baxalta GmbH and Takeda Pharmaceutical Company Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmacokinetics.
Collaborations
Wolfsegger has collaborated with several professionals in his field, including Kameswara Rao Kuchimanchi and Alexandra Loew-Baselli. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Martin Wolfsegger is a distinguished inventor whose work in pharmacokinetic drug dosing regimens has the potential to transform patient treatment strategies. His innovative approaches and collaborations highlight his commitment to improving healthcare outcomes.